Our verdict is Uncertain significance. Variant got 2 ACMG points: 4P and 2B. PM1PM2BP4_Moderate
The NM_032523.4(OSBPL6):c.104G>A(p.Ser35Asn) variant causes a missense, splice region change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 16/23 in silico tools predict a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (★).
OSBPL6 (HGNC:16388): (oxysterol binding protein like 6) This gene encodes a member of the oxysterol-binding protein (OSBP) family, a group of intracellular lipid receptors. Most members contain an N-terminal pleckstrin homology domain and a highly conserved C-terminal OSBP-like sterol-binding domain. Transcript variants encoding different isoforms have been identified. [provided by RefSeq, Jul 2008]
Review Status: criteria provided, single submitter
Collection Method: clinical testing
The c.104G>A (p.S35N) alteration is located in exon 4 (coding exon 2) of the OSBPL6 gene. This alteration results from a G to A substitution at nucleotide position 104, causing the serine (S) at amino acid position 35 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Loss of phosphorylation at S35 (P = 0.005);Loss of phosphorylation at S35 (P = 0.005);Loss of phosphorylation at S35 (P = 0.005);Loss of phosphorylation at S35 (P = 0.005);Loss of phosphorylation at S35 (P = 0.005);Loss of phosphorylation at S35 (P = 0.005);.;